What one share of Jaguar Health holds
Jaguar Health, Inc. (“Jaguar”), in conjunction with Jaguar family company Napo Pharmaceuticals, Inc. (“Napo”), develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal (“GI”) disease states.
Jaguar Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $83.31 |
|---|---|
| Profit | −$157.00 |
| Cash and investments | $4.68 |
| Debt | $19.23 |
| Book value | $6.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2025 | $172.73 | −$803.95 | — | — | — | −$280.43 |
Common questions about Jaguar Health
How much does one share of Jaguar Health earn?
Over the last 12 months, Jaguar Health lost $157.00 for each share on $83.31 of sales.
Does Jaguar Health pay a dividend?
Jaguar Health didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Jaguar Health’s book value per share?
Jaguar Health’s book value is $6.08 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Jaguar Health have?
Each share of Jaguar Health has $4.68 of cash and investments and $19.23 of debt, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.